Reprogramming CD8+ T cells

MEK1/2 inhibition enhances both the persistence and antitumor activity of CD8+ T cells in vivo.

Source: Signal Transduction Knowledge Environment - January 26, 2021 Category: Science Authors: Foley, J. F. Tags: STKE Editors ' Choice Source Type: news